Moderna Continues mRNA Norovirus “Vaccine” Trials Following Guillain-Barré Case
A first-ever norovirus “vaccine”—another experimental biological product produced by Moderna, Inc., using novel mRNA technology—may be on the horizon even though last month the U.S. Food and Drug Administration (FDA) paused Moderna’s late-stage clinical trial following a report of Guillain-Barré syndrome (GBS), a rare neurological side effect that has also surfaced in its RSV vaccine […]
FDA Approves Freeze-Dried Smallpox/Mpox Vaccine
On Mar. 31, 2025, the U.S. Food and Drug Administration (FDA) approved the freeze-dried formulation of Bavarian Nordic A/S’s Jynneos vaccine for smallpox and mpox (formerly monkey pox) in adults 18 years of age and older. The liquid-frozen formulation of the vaccine was approved by the FDA on Sept. 24, 2019, but that version requires […]
CDC Picks Thimerosal Researcher for Vaccines, Autism Study
On Mar. 7, 2025, the Associated Press and other media sources reported that the U.S. Centers for Disease Control and Prevention (CDC) is planning to conduct a study to determine possible links between vaccines and autism. In a prepared statement, the DHHS vaccine policymaking agency said that the “CDC will leave no stone unturned in its […]
NC Court Sides With Merck in Class Action Gardasil Vaccine Injury Lawsuit
The District Court in North Carolina sided with Merck & Co. and granted a summary judgment motion to dismiss plaintiff’s failure to warn claims in ongoing litigation between the pharmaceutical giant and young women injured by the Gardasil vaccine. The lawsuit alleged that Merck covered up the risks associated with the company’s blockbuster vaccine which […]
CDC Plans to Conduct Study on Reported Link Between Vaccines and Autism
The U.S. Centers for Disease Control and Prevention (CDC) is planning to conduct a study to explore persistent reports that there is a link between vaccines and autism, according to a Mar. 7, 2025 report first published by Reuters1 and followed by The Washington Post on Mar. 7, 2025.2 A Department of Health and Human Services […]
COVID Antiviral Paxlovid Provides “No Significant Benefit” to Vaccinated Seniors
Paxlovid, the antiviral drug that became the go-to treatment for SARS-CoV-2 infections during the pandemic, did not reduce hospitalizations or death in older adults who had gotten COVID-19 shots, according to a new study published in the Journal of the American Medical Association (JAMA) last month. Researchers who tested the COVID treatment Paxlovid (nirmatrelvir-ritonavir) on […]